Business Description
Fennec Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA31447P1009
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | -0.43 | |||||
Debt-to-Equity | -2.66 | |||||
Debt-to-EBITDA | -2.48 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -7.37 | |||||
Beneish M-Score | 8.18 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 392.2 | |||||
3-Year EBITDA Growth Rate | 13.9 | |||||
3-Year EPS without NRI Growth Rate | 6.4 | |||||
3-Year FCF Growth Rate | -0.9 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.39 | |||||
9-Day RSI | 31.85 | |||||
14-Day RSI | 35.72 | |||||
6-1 Month Momentum % | 51.91 | |||||
12-1 Month Momentum % | 37.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.56 | |||||
Quick Ratio | 3.27 | |||||
Cash Ratio | 1.76 | |||||
Days Inventory | 397.43 | |||||
Days Sales Outstanding | 65.36 | |||||
Days Payable | 876.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | -4.76 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 94.08 | |||||
Operating Margin % | -61.27 | |||||
Net Margin % | -75.69 | |||||
FCF Margin % | -80.82 | |||||
ROA % | -70.22 | |||||
ROIC % | -659.7 | |||||
ROC (Joel Greenblatt) % | -407.99 | |||||
ROCE % | -70.02 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 29.67 | |||||
PS Ratio | 11.72 | |||||
EV-to-EBIT | -21.39 | |||||
EV-to-EBITDA | -21.76 | |||||
EV-to-Revenue | 12.77 | |||||
EV-to-Forward-Revenue | 5.1 | |||||
EV-to-FCF | -15.78 | |||||
Earnings Yield (Greenblatt) % | -4.68 | |||||
FCF Yield % | -6.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Fennec Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 19.667 | ||
EPS (TTM) (€) | -0.567 | ||
Beta | 0.98 | ||
Volatility % | 51.61 | ||
14-Day RSI | 35.72 | ||
14-Day ATR (€) | 0.276235 | ||
20-Day SMA (€) | 9.385 | ||
12-1 Month Momentum % | 37.24 | ||
52-Week Range (€) | 5.95 - 10.4 | ||
Shares Outstanding (Mil) | 27.1 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fennec Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fennec Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Fennec Pharmaceuticals Inc Frequently Asked Questions
What is Fennec Pharmaceuticals Inc(STU:RV41)'s stock price today?
When is next earnings date of Fennec Pharmaceuticals Inc(STU:RV41)?
Does Fennec Pharmaceuticals Inc(STU:RV41) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |